These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 15159020)
21. Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein. van de Donk NW; Kamphuis MM; van Dijk M; Borst HP; Bloem AC; Lokhorst HM Leukemia; 2003 Jan; 17(1):211-9. PubMed ID: 12529680 [TBL] [Abstract][Full Text] [Related]
22. Involvement of Bcl-2 family, cytochrome c and caspase 3 in induction of apoptosis by beauvericin in human non-small cell lung cancer cells. Lin HI; Lee YJ; Chen BF; Tsai MC; Lu JL; Chou CJ; Jow GM Cancer Lett; 2005 Dec; 230(2):248-59. PubMed ID: 16297711 [TBL] [Abstract][Full Text] [Related]
23. Down-modulation of survivin expression and inhibition of tumor growth in vivo by EZN-3042, a locked nucleic acid antisense oligonucleotide. Sapra P; Wang M; Bandaru R; Zhao H; Greenberger LM; Horak ID Nucleosides Nucleotides Nucleic Acids; 2010 Feb; 29(2):97-112. PubMed ID: 20391197 [TBL] [Abstract][Full Text] [Related]
24. Quercetin down-regulated bcl-2 gene expression in human leukemia HL-60 cells. Xiao D; Gu ZL; Zhu SP Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):551-3. PubMed ID: 10437144 [TBL] [Abstract][Full Text] [Related]
25. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug. Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631 [TBL] [Abstract][Full Text] [Related]
26. [Regulatory effect of STAT5 decoy oligonucleotides on trans-activation of bcl-x gene promoter in K562 cells]. Zeng JM; Feng WL; Wang XZ; Shi M; Tu ZG; Huang ZG Ai Zheng; 2005 Apr; 24(4):414-8. PubMed ID: 15820062 [TBL] [Abstract][Full Text] [Related]
27. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961 [TBL] [Abstract][Full Text] [Related]
28. Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancer. Hu Y; Bebb G; Tan S; Ng R; Yan H; Sartor JR; Mayer LD; Bally MB Clin Cancer Res; 2004 Nov; 10(22):7662-70. PubMed ID: 15569999 [TBL] [Abstract][Full Text] [Related]
29. Role of mitochondria in quercetin-enhanced chemotherapeutic response in human non-small cell lung carcinoma H-520 cells. Kuhar M; Sen S; Singh N Anticancer Res; 2006; 26(2A):1297-303. PubMed ID: 16619537 [TBL] [Abstract][Full Text] [Related]
30. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity. Tirado OM; Mateo-Lozano S; Notario V Oncogene; 2005 May; 24(20):3348-57. PubMed ID: 15782132 [TBL] [Abstract][Full Text] [Related]
31. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells. Yamanaka K; Rocchi P; Miyake H; Fazli L; Vessella B; Zangemeister-Wittke U; Gleave ME Mol Cancer Ther; 2005 Nov; 4(11):1689-98. PubMed ID: 16275990 [TBL] [Abstract][Full Text] [Related]
32. Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L). Ke H; Pei J; Ni Z; Xia H; Qi H; Woods T; Kelekar A; Tao W Exp Cell Res; 2004 Aug; 298(2):329-38. PubMed ID: 15265683 [TBL] [Abstract][Full Text] [Related]
33. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells. Villedieu M; Louis MH; Dutoit S; Brotin E; Lincet H; Duigou F; Staedel C; Gauduchon P; Poulain L Gynecol Oncol; 2007 Apr; 105(1):31-44. PubMed ID: 17275076 [TBL] [Abstract][Full Text] [Related]
35. Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells. Sun Y; Sun D; Li F; Tian L; Li C; Li L; Lin R; Wang S Lung Cancer; 2007 Oct; 58(1):21-9. PubMed ID: 17624472 [TBL] [Abstract][Full Text] [Related]
36. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer. Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464 [TBL] [Abstract][Full Text] [Related]
37. Implication of bax in apoptosis depends on microtubule network mobility. Longuet M; Serduc R; Riva C Int J Oncol; 2004 Aug; 25(2):309-17. PubMed ID: 15254727 [TBL] [Abstract][Full Text] [Related]
38. [Effect of compound Rhizoma Smilacinus granules on the expression of Bcl-2 and Bax gene in A549 cell lines of non-small cell lung cancers]. Li GC; Dong KL; Hu CH Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):312-5. PubMed ID: 17478943 [TBL] [Abstract][Full Text] [Related]
39. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. Brenes O; Arce F; Gätjens-Boniche O; Díaz C Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942 [TBL] [Abstract][Full Text] [Related]